drug delivery technology the science & business of specialty pharma biotechnology and 2007 media planner global industry has grown from just under 20 billion in product revenue 1995 to nearly 70 today is a well established vitally important segment pharmaceutical source valeo partners market t he i mpact d rug elivery approval development systems are cornerstones as industries discover challenging new compounds that require sophisticated incorporated products otherwise could not be developed life cycle management technologies have proven an effective way extend cycles existing by enabling improved therapeutic performance also used molecular entities nmes can achieve speedier acceptance larger share longer improving safety drugs often fail win regulatory because adverse side effects on patients reducing or eliminating these efficacy releasing right amount
